Leerink Partners Starts Monopar Therapeutics (MNPR) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: MNPR) | Delayed: 70.73 -1.85 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.58 | 52 Week High | $ | |||
| Open | $71.84 | 52 Week Low | $ | |||
| Day High | $71.84 | P/E | N/A | |||
| Day Low | $69.48 | EPS | $ | |||
| Volume | 40,180 | |||||
